This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Hesketh, Paul
| Item Type | Name |
|
Concept
|
Administration, Oral
|
|
Academic Article
|
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
|
|
Academic Article
|
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
|
|
Academic Article
|
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.
|
|
Academic Article
|
Oral ondansetron: a useful addition to the supportive care armamentarium?
|
|
Academic Article
|
Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
|
|
Academic Article
|
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.
|
|
Academic Article
|
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
|
|
Academic Article
|
Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
|
|
Academic Article
|
Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.
|
|
Academic Article
|
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
|
|
Academic Article
|
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.
|
|
Academic Article
|
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
|